Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria.

By K. Kortright, B. Chan, J. Koff, P. Turner. Cell Host and Microbe, 2019

1,036 citations recorded by the source corpus.

Phage therapy, long overshadowed by chemical antibiotics, is garnering renewed interest in Western medicine. This stems from the rise in frequency of multi-drug-resistant bacterial infections in humans. There also have been recent case reports of phage therapy demonstrating clinical utility in resolving these otherwise intractable infections. Nevertheless, bacteria can readily evolve phage resistance too, making it crucial for modern phage therapy to develop strategies to capitalize on this inevitability. Here, we review the history of phage therapy research. We compare and contrast phage therapy and chemical antibiotics, highlighting their potential synergies when used in combination. We also examine the use of animal models, case studies, and results from clinical trials. Throughout, we explore how the modern scientific community works to improve the reliability and success of phage therapy in the clinic and discuss how to properly evaluate the potential for phage therapy to combat antibiotic-resistant bacteria.

Subfields: Ecology, Microbiology, Plant Science

View Paper: https://www.semanticscholar.org/paper/bce2f42af8e0db9de8acd433a0db285a8b6cbafb

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Citations in the corpus

Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It (2020, background): “So far, there are only a few reports on the clinical use of bacteriophages [58,61].”